Skip to main content
. 2021 May 6;13:17588359211012982. doi: 10.1177/17588359211012982

Figure 2.

Figure 2.

Overall survival analysis for hormone receptor and molecular typing conversion. (a) ER status in primary and metastatic sites. (b) PR status in primary and metastatic sites. (c) Molecular typing in primary and metastatic sites.